News ListTuesday 07. of August 2007 Ipsogen expands and opens New Haven office to market its leukaemia molecular diagnostic products in North AmericaIpsogen, Inc., founded in March 2005 as a subsidiary of Ipsogen SAS, a leading provider of molecular diagnostics in oncology headquartered in Marseille, France, today announced the opening of its new facilities in New Haven,... Category: Corporate
 Friday 24. of June 2005 Ipsogen receives 2005 "Price for Innovation"Marseille, France, June, 23th 2005 For 4 years, Siemens, a world leader of the patent registration of invention, with 5000 patents registered last year, awards trophies to the most innovative companies in France. The main... Category: Corporate
Thursday 19. of May 2005 Genaissance Pharmaceuticals and Ipsogen announce cancer biomarker research agreementsNew Haven, CT, and Marseille, France, September 12, 2005 – Read more Privately-held Ipsogen SAS and Genaissance Pharmaceuticals, Inc. (NASDAQ: GNSC) announced today that they have signed collaboration agreements with two... Category: Corporate
Tuesday 15. of March 2005 Ipsogen announces the recent opening of additional offices in the USA, further expanding its ability to deliver a growing range of oncodiagnostic products worldwideMarseille, France, March 15, 2005 – Located in Windsor Connecticut, the formation of Ipsogen Inc. provides the company with expanded direct sales capabilities and effective local product support in North America. Ipsogen Inc.... Category: Corporate
Wednesday 17. of November 2004 Ipsogen and Genaissance Pharmaceuticals, Inc. announce a co-marketing agreementMarseille, France and New Haven, CT , November 17, 2004 - Privately held Ipsogen and Genaissance Pharmaceuticals, Inc. (NASDAQ: GNSC) announced today that the two companies had signed a co-marketing agreement, under which the... Category: Corporate
Friday 28. of November 2003 Ipsogen announces two global exclusive agreements with the Université de la Méditerranée to expand its diagnostic platform in oncology.Marseille, France, November 28 "We are delighted to enter into this agreement with the UNIVERSITÉ DE LA MÉDITERRANÉE, which will enable us to provide state-of-the-art standardised molecular diagnostic tools" said... Category: Corporate
Thursday 11. of September 2003 Ipsogen and Fox Chase Center announce a bioinformatics collaboration to improve analysis, validation , standardisation and interpretation of data generated by large scale gene expression analysis.IPSOGEN
The first part of the collaboration is dedicated to the study of an acute myeloid leukaemia dataset obtained in close collaboration with IPSOGEN clinical partner, the Institut Paoli-Calmettes. Approximately 40% to 50%... Category: Corporate
Wednesday 03. of September 2003 Ipsogen and Oncodesign announce a partnership to accelerate the discovery and development of anticancer drugs.Marseille, France. IPSOGEN Read more and ONCODESIGN today announced the signing of a partnership agreement which combines the expertise of ONCODESIGN in anticancer therapy discovery via its pharmacology platform (in vitro... Category: Corporate
Tuesday 10. of September 2002 Ipsogen launches a new Gene Expression Profiling service for clinical centresMARSEILLE, France, September 10th, 2002 - IPSOGEN today announced the launch of a new gene profiling service dedicated to clinical oncology centres. This unique service is aimed at expert centres that want to offer... Category: Corporate
Tuesday 05. of March 2002 Ipsogen appoints a Quality and Regulatory Affairs ManagerMARSEILLE, France, March 5, 2002 -- IPSOGEN today announced the appointment of Vincent Castéras, as Quality and Regulatory Affairs Manager. Vincent joins IPSOGEN from Cardiff University (Wales, UK), where he worked as a Research... Category: Corporate
Displaying results 11 to 20 out of 21 |
|
